| Jumpcode Genomics
Health Care · Genomics & Genetic Testing
$38.7Mtotal raised · 6 rounds on record
$3.5Mlatest round · Venture round · Aug 2024 · 2 yr ago
1backers · Arboretum Ventures
$384kgrants · 1 grant · CORDIS
Overview
The majority of molecules sequenced are uninformative. Jumpcode Genomics is changing that by helping researchers boost usable NGS data.
Funding and backers
Total raised
$38.7M
6 rounds on record
Latest round
$3.5M
Venture round · Aug 2024 · 2 yr ago
Team
10
US Form 5500 (plan participants) · Dec 2024
Grants
$384k
1 grant · CORDIS
Backers
1
Arboretum Ventures
The money's age
Long since its last round
26 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 3, 2025
Won a grant $384k · CORDIS
Aug 15, 2024
Raised a round Venture round $3.5M · SEC Form D
Apr 27, 2023
Raised a round Venture round $9.2M · SEC Form D
Dec 18, 2020
Raised a round Venture round $21M · SEC Form D
Jan 27, 2020
Raised a round Venture round $1.5M · SEC Form D
Sep 4, 2018
Raised a round Venture round $3.5M · SEC Form D
2016
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Mar 2025 | $384k | — | CORDIS |
| Venture round | Aug 2024 | $3.5M | — | SEC Form D |
| Venture round | Apr 2023 | $9.2M | — | SEC Form D |
| Venture round | Dec 2020 | $21M | — | SEC Form D |
| Venture round | Jan 2020 | $1.5M | — | SEC Form D |
| Venture round | Sep 2018 | $3.5M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | JumpCode Genomics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Keith BrownExecutive OfficerSEC Form D
Yaron HakakExecutive Officer, DirectorSEC Form D
Brandon PoeExecutive OfficerSEC Form D
David SalterExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Basepair offers advanced NGS data analysis platform for academic, commercial, and clinical research. Try it today!
ゲノム （ DNA ）、エピゲノム、トランスクリプトーム （ RNA ）を独自の技術で解析し、研究開発の効率・精度を格段に向上させます。次世代シーケンス（ NGS ）／ エピジェネティクス 研究の 実験デザイン から 情報 解析、論文化、事業化までオーダーメイドで支援します。.
Learn howCanal's TrueLink® NGS technology safeguards your template without the need for end repair.
Reduce expert workload per NGS case by up to 85%. Qnomx leverages AI to streamline NGS interpretation and generate clinician-ready reports.
SeqWell delivers true multiplexing NGS library prep solutions using stunningly simple workflows.
Bespoke NGS solutions for different clinical indications, without compromising in accuracy, content, performance or simplicity.
Financials
Total raised
$39.1M
Latest round
Grant
Funding rounds
6
People
Keith Brown
Executive Officer
Yaron Hakak
Executive Officer, Director
Brandon Poe
Executive Officer
David Salter
Executive Officer, Director
Eugene Chen
Director
Joel Rotroff
Director
Kirk Malloy
Director
Kevin Li
Director
Dan Kidle
Director
Frank Witney
Director
Michael Liang
Director
Court Turner
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Arboretum VenturesVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Jumpcode Genomics Announces License Agreement with ERS Genomics
License agreement provides Jumpcode Genomics access to CRISPR gene editing technology to enhance next-generation sequencing capabilities Dublin, Ireland, and San Diego, CA, 27 March, 2025: ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Ju
Read more
Report
Jumpcode Genomics
Research outputs, collaborations and relationships for Jumpcode Genomics
Read more
Report
Jumpcode Genomics
Research outputs, collaborations and relationships for Jumpcode Genomics
Read more
Report
Jumpcode Genomics Partners with Ginkgo Bioworks as part of the Ginkgo Technology Network
inkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the creation of the Ginkgo Technology Network - a groundbreaking ecosystem of cutting edge technology partners, each committed to coll
Read more
Report
Takara Bio USA Wins EU Opposition Hearing, Revoking Jumpcode Genomics' NGS Library Enrichment Patent
Read more
Report
New Study Shows Improved Genotyping by Sequencing with in vitro Repeat Depletion
SAN DIEGO, Calif. - June 20, 2023 - Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, today announced the results of a study demonstrating the ability to improve genotyping through CRISPR-Cas9
Read more
Report
New Research Demonstrates Potential of Jumpcode Genomics Depletion Technology to Improve Pandemic Response
SAN DIEGO, Calif. - May 1, 2023 - Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, together with the Translational Genomics Research Institute (TGen), part of City of Hope, today announced th
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Carlsbad
United States
HQ
50-200 est. staff